Search

Search Constraints

You searched for: Author/Creator Teshigawara, S.

Search Results

1. AB0282 Predicting The Responses To Biological Therapy by Two Kinds of Antibodies Titers against Porphyromonas Gingivalis in RA Patients. (15th July 2016)

2. AB0449 Baseline Procalcitonin (PCT) Level as A Predictive Marker for Clinical Remission (DAS28-ESR, CDAI) at 52 Weeks in Biologic NaÏVe Rheumatoid Arthritis (RA) Patients Treated by TOCILIZUMAB (TCZ); A Single Center Retrospective Study. (10th June 2014)

3. AB0940 The Prevalence of Achalasia among Patients with Autoimmune Diseases. (10th June 2014)

4. AB0943 Monocyte/Neutrophil (M/N) CD64 Ratio is Useful for Differentiating Infection from Disease Activity in Systemic Lupus Erythematosus (SLE) Patients. (10th June 2014)

5. FRI0079 Plasma Pentraxin3 (PTX3) as A Novel Useful Biomarker for Infection in Patients with Rheumatoid Arthritis (RA). (10th June 2014)

6. FRI0091 Neutrophil CD64 (NCD64) as A Useful Marker for Differentiating Organizing Pneumonia (OP) from Bacterial Pneumonia (BP) in Rheumatoid Arthritis (RA). (10th June 2014)

7. OP0191 The Fecal Microbiota of Rheumatoid Arthritis Patients Differs from that of Healthy Volunteers and is Considerably Altered by Treatment with Biologics. (23rd January 2014)

8. SAT0002 Quantitative CD64 Molecules on Peripheral Blood Monocytes in Systemic Lupus Erythematosus (SLE). (10th June 2014)

9. SAT0003 Quantitative Monocyte CD64 (MCD64) Expression is Useful Biomarker for Disease Activity in Systemic Lupus Erythematosus (SLE) Patients. (10th June 2014)

10. SAT0059 Association of Serum Antibody Responses to Porphyromonas Gingivalis and Periodontal Conditions with Clinical Response to Biologics in Rheumatoid Arthritis Patients. (23rd January 2014)